123 related articles for article (PubMed ID: 18475014)
1. Plasma brain natriuretic peptide level after hybrid therapy with pulmonary vein isolation and antiarrhythmic drugs for atrial fibrillation.
Yamada T; Murakami Y; Okada T; Yoshida N; Toyama J; Yoshida Y; Tsuboi N; Inden Y; Hirai M; Murohara T
Int Heart J; 2008 Mar; 49(2):143-51. PubMed ID: 18475014
[TBL] [Abstract][Full Text] [Related]
2. Predictive value of B-type natriuretic peptide levels in patients with paroxysmal and persistent atrial fibrillation undergoing pulmonary vein isolation.
Degener S; Pattberg SV; Feuersenger H; Bansmann PM; Shin DI; Krummenauer F; Horlitz M
J Interv Card Electrophysiol; 2011 Apr; 30(3):217-25. PubMed ID: 21249437
[TBL] [Abstract][Full Text] [Related]
3. Plasma brain natriuretic peptide concentrations in patients undergoing pulmonary vein isolation.
Date T; Yamane T; Inada K; Matsuo S; Miyanaga S; Sugimoto K; Shibayama K; Taniguchi I; Mochizuki S
Heart; 2006 Nov; 92(11):1623-7. PubMed ID: 16740921
[TBL] [Abstract][Full Text] [Related]
4. Plasma atrial natriuretic Peptide and brain natriuretic Peptide levels after radiofrequency catheter ablation of atrial fibrillation.
Yamada T; Murakami Y; Okada T; Okamoto M; Shimizu T; Toyama J; Yoshida Y; Tsuboi N; Ito T; Muto M; Kondo T; Inden Y; Hirai M; Murohara T
Am J Cardiol; 2006 Jun; 97(12):1741-4. PubMed ID: 16765125
[TBL] [Abstract][Full Text] [Related]
5. Addition of B-Type Natriuretic Peptide to Existing Clinical Risk Scores Enhances Identification of Patients at Risk for Atrial Fibrillation Recurrence After Pulmonary Vein Isolation.
Shaikh AY; Esa N; Martin-Doyle W; Kinno M; Nieto I; Floyd KC; Browning C; Ennis C; Donahue JK; Rosenthal LS; McManus DD
Crit Pathw Cardiol; 2015 Dec; 14(4):157-65. PubMed ID: 26569657
[TBL] [Abstract][Full Text] [Related]
6. Fast atrial activity predicts recurrence of atrial fibrillation after pulmonary vein isolation: results from a prospective randomized study.
Kriatselis C; Kaufmann J; Nedios S; Liu J; Gerds-Li JH; Fleck E
J Interv Card Electrophysiol; 2015 Mar; 42(2):101-6. PubMed ID: 25591723
[TBL] [Abstract][Full Text] [Related]
7. PulmOnary vein isolation With vs. without continued antiarrhythmic Drug trEatment in subjects with Recurrent Atrial Fibrillation (POWDER AF): results from a multicentre randomized trial.
Duytschaever M; Demolder A; Phlips T; Sarkozy A; El Haddad M; Taghji P; Knecht S; Tavernier R; Vandekerckhove Y; De Potter T
Eur Heart J; 2018 Apr; 39(16):1429-1437. PubMed ID: 29211857
[TBL] [Abstract][Full Text] [Related]
8. Plasma brain natriuretic peptide level after radiofrequency catheter ablation of paroxysmal, persistent, and permanent atrial fibrillation.
Yamada T; Murakami Y; Okada T; Yoshida N; Toyama J; Yoshida Y; Tsuboi N; Inden Y; Hirai M; Murohara T
Europace; 2007 Sep; 9(9):770-4. PubMed ID: 17670784
[TBL] [Abstract][Full Text] [Related]
9. Ganglionated plexus ablation vs linear ablation in patients undergoing pulmonary vein isolation for persistent/long-standing persistent atrial fibrillation: a randomized comparison.
Pokushalov E; Romanov A; Katritsis DG; Artyomenko S; Shirokova N; Karaskov A; Mittal S; Steinberg JS
Heart Rhythm; 2013 Sep; 10(9):1280-6. PubMed ID: 23608592
[TBL] [Abstract][Full Text] [Related]
10. Baseline B-type natriuretic peptide: a gender-specific predictor of procedure-outcome in atrial fibrillation patients undergoing catheter ablation.
Mohanty S; Mohanty P; Di Biase L; Rong B; Burkhardt D; Gallinghouse JG; Horton R; Sanchez JE; Bailey S; Zagrodzky J; Natale A
J Cardiovasc Electrophysiol; 2011 Aug; 22(8):858-65. PubMed ID: 21371160
[TBL] [Abstract][Full Text] [Related]
11. The impact of B-type natriuretic peptide levels on the suppression of accompanying atrial fibrillation in Wolff-Parkinson-White syndrome patients after accessory pathway ablation.
Kawabata M; Goya M; Takagi T; Yamashita S; Iwai S; Suzuki M; Takamiya T; Nakamura T; Hayashi T; Yagishita A; Sasaki T; Takahashi Y; Ono Y; Hachiya H; Yamauchi Y; Otomo K; Nitta J; Okishige K; Nishizaki M; Iesaka Y; Isobe M; Hirao K
J Cardiol; 2016 Dec; 68(6):485-491. PubMed ID: 26917195
[TBL] [Abstract][Full Text] [Related]
12. Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial.
Wazni OM; Marrouche NF; Martin DO; Verma A; Bhargava M; Saliba W; Bash D; Schweikert R; Brachmann J; Gunther J; Gutleben K; Pisano E; Potenza D; Fanelli R; Raviele A; Themistoclakis S; Rossillo A; Bonso A; Natale A
JAMA; 2005 Jun; 293(21):2634-40. PubMed ID: 15928285
[TBL] [Abstract][Full Text] [Related]
13. NT-proBNP, but not ANP and C-reactive protein, is predictive of paroxysmal atrial fibrillation in patients undergoing pulmonary vein isolation.
Fan J; Cao H; Su L; Ling Z; Liu Z; Lan X; Xu Y; Chen W; Yin Y
J Interv Card Electrophysiol; 2012 Jan; 33(1):93-100. PubMed ID: 21938519
[TBL] [Abstract][Full Text] [Related]
14. Elevated brain natriuretic peptide level in patients undergoing atrial fibrillation ablation: is it a predictor of failed ablation or a mere function of atrial rhythm and rate at a point in time?
Pillarisetti J; Reddy N; Biria M; Ryschon K; Nagarajan D; Murray C; Atkins D; Bommana S; Reddy MY; DiBiase L; Pimentel R; Berenbom L; Dawn B; Natale A; Lakkireddy D
J Interv Card Electrophysiol; 2014 Aug; 40(2):161-8. PubMed ID: 24800931
[TBL] [Abstract][Full Text] [Related]
15. Recurrence of paroxysmal atrial fibrillation after pulmonary vein isolation: is repeat pulmonary vein isolation enough? A prospective, randomized trial.
Fichtner S; Sparn K; Reents T; Ammar S; Semmler V; Dillier R; Buiatti A; Kathan S; Hessling G; Deisenhofer I
Europace; 2015 Sep; 17(9):1371-5. PubMed ID: 25694536
[TBL] [Abstract][Full Text] [Related]
16. Stand-Alone Pulmonary Vein Isolation Versus Pulmonary Vein Isolation With Additional Substrate Modification as Index Ablation Procedures in Patients With Persistent and Long-Standing Persistent Atrial Fibrillation: The Randomized Alster-Lost-AF Trial (Ablation at St. Georg Hospital for Long-Standing Persistent Atrial Fibrillation).
Fink T; Schlüter M; Heeger CH; Lemes C; Maurer T; Reissmann B; Riedl J; Rottner L; Santoro F; Schmidt B; Wohlmuth P; Mathew S; Sohns C; Ouyang F; Metzner A; Kuck KH
Circ Arrhythm Electrophysiol; 2017 Jul; 10(7):. PubMed ID: 28687670
[TBL] [Abstract][Full Text] [Related]
17. Predicting successful pulmonary vein isolation in patients with atrial fibrillation by brain natriuretic Peptide plasma levels.
Shin DI; Deneke T; Gorr E; Anders H; Buenz K; Paesler M; Horlitz M
Indian Pacing Electrophysiol J; 2009 Sep; 9(5):241-6. PubMed ID: 19763191
[TBL] [Abstract][Full Text] [Related]
18. Endothelin-1 as a predictor of atrial fibrillation recurrence after pulmonary vein isolation.
Nakazawa Y; Ashihara T; Tsutamoto T; Ito M; Horie M
Heart Rhythm; 2009 Jun; 6(6):725-30. PubMed ID: 19467500
[TBL] [Abstract][Full Text] [Related]
19. Biatrial linear ablation in sustained nonpermanent AF: Results of the substrate modification with ablation and antiarrhythmic drugs in nonpermanent atrial fibrillation (SMAN-PAF) trial.
Wynn GJ; Panikker S; Morgan M; Hall M; Waktare J; Markides V; Hussain W; Salukhe T; Modi S; Jarman J; Jones DG; Snowdon R; Todd D; Wong T; Gupta D
Heart Rhythm; 2016 Feb; 13(2):399-406. PubMed ID: 26455343
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of additional radiofrequency applications for spontaneous dissociated pulmonary vein activity after pulmonary vein isolation in patients with paroxysmal atrial fibrillation.
Doi A; Satomi K; Makimoto H; Yokoyama T; Yamada Y; Okamura H; Noda T; Aiba T; Aihara N; Yasuda S; Ogawa H; Kamakura S; Shimizu W
J Cardiovasc Electrophysiol; 2013 Aug; 24(8):894-901. PubMed ID: 23601079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
